Novel Drug Lowers Stubbornly High BP in Phase 3 Trial ...Middle East

Lorundrostat, an aldosterone synthase inhibitor, effectively treated uncontrolled hypertension in Launch-HTN, researchers reported in JAMA. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Novel Drug Lowers Stubbornly High BP in Phase 3 Trial )

Also on site :

SunCar's Partnership with Xiaomi Enters a New Phase to Support its YU7 Launch, Promoting Fully Intelligent Auto Insurance
Luann de Lesseps Reveals Why 'RHONY' Reboot Never Clicked for Fans, Shares If She'd Return (Exclusive)
The Clever Coffee Hack Brain Experts Swear By for Better Focus and Energy

Novel Drug Lowers Stubbornly High BP in Phase 3 Trial ...Middle East

Silicon Motion Announces the Addition of Jeffrey Ju as Senior Vice President of Platform & Strategy

Five years later, the pandemic still weakens two California employee safety nets

Warren Buffett donates another $6 billion in Berkshire Hathaway shares—with the lion’s share going to the Gates Foundation

‘Every Time You Lose Your Mind’: ’90s Alt-Rockers Failure Talk Their Long-Awaited Documentary and Rewriting Their “Tumultuous” Legacy

Seven Changes That Finally Helped Me Stick to My Home Fitness Routine

Orioles Place Zach Eflin On Injured List

Americans Have Never Hated Being American More, New Poll Finds

Costco Fans are Willing to Travel '16 Hours' for Flavorful International Drop: 'Why Can't We Have Nice Things?'

Blame the "Target Effect" For Your Impulsive Spending Habits

Sen. Mark Warner Tired of GOP Colleagues Telling Him How Terrible the BBB Is in Private

The 5:00 News – Carrboro Wins All-America City, OCS Summer Projects

AI Is Making the Internet Weird Again—And That's a Good Thing

Rookie Paige Bueckers named WNBA All-Star starter. Nneka Ogwumike selected for 10th time

Willie Nelson’s Outlaw Music Festival Tour Hits Pause After Extreme Weather Damages Gear

Warm Tuesday, slight cooling follows